ArticleNature reviews. Clinical oncology2010
Immunotherapy. Significant overall survival advantage for RCC patients treated with autologous tumor lysate vaccine.
Lisa HutchinsonPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it